MS-SMART: Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial

NCT01910259 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

445

Enrollment

OTHER

Sponsor class

Conditions

Secondary Progressive Multiple Sclerosis

Interventions

DRUG: Amiloride
DRUG: Riluzole
DRUG: Fluoxetine
DRUG: Placebo

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]